Literature DB >> 33079271

Mechanism by which the combination of SjCL3 and SjGAPDH protects against Schistosoma japonicum infection.

Wenling Huang1, Mengjie Gu1, Wenjun Cheng1, Shuhong Wang1, Kaijie Li1,2, Qin Ping Zhao1, Zhenping Ming1, Huifen Dong3.   

Abstract

A vaccine is an important method to control schistosomiasis. Molecules related to lung-stage schistosomulum are considered potential vaccine candidates. We previously showed that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and cathepsin L3 (CL3) displayed differential expression in the lung-stage schistosomula of Schistosoma japonicum cocultured with host cells. In the present study, we prepared the two proteins and detected the protective effects of SjGAPDH by immunizing mice with this protein alone and in combination with SjCL3 with or without Freund's adjuvant. Then, we investigated the possible mechanisms underlying S. japonicum infection. The results showed that vaccination of adjuvanted SjGAPDH decreased the worm burden (37.8%) and egg load (38.1%), and the combination of adjuvanted SjGAPDH and SjCL3 further decreased the worm burden (65.6%) and egg load (70.9%) during Schistosoma japonicum infection. However, the immunization of a combination of adjuvant-free SjGAPDH and SjCL3 displayed a lower protective effect (< 15%) than those of the adjuvanted SjCL3, the adjuvanted SjGAPDH, and a combination of adjuvanted SjGAPDH and SjCL3. Flow cytometric results showed that the frequency of regulatory T cells (Tregs) was lower (P < 0.05) in the group with adjuvanted SjGAPDH and SjCL3 (2.61%) than the remaining groups. The enzyme-linked immunosorbent assay (ELISA) results indicated that except for the uninfected and infected control groups, the remaining groups displayed a Th1-type shift in immune responses. These results showed the immunization of SjGAPDH resulted in partial protection (approximately 38%); inoculation with a combination of SjCL3 and SjGAPDH in Freund's adjuvant resulted in a high immunoprotective effect (> 65%) against Schistosoma japonicum infection in mice, which was possibly caused by the reduced percentage of Tregs and a Th1-type shift in immune responses; and SjCL3 has no adjuvant-like effect, dissimilar to SmCL3.

Entities:  

Keywords:  Cathepsin L3; GAPDH; Immunoprotection; Schistosoma japonicum; Tregs

Year:  2020        PMID: 33079271     DOI: 10.1007/s00436-020-06916-9

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  51 in total

1.  Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.

Authors:  L L Argiro; S S Kohlstädt; S S Henri; H H Dessein; V V Matabiau; P P Paris; A A Bourgois; A J Dessein
Journal:  Vaccine       Date:  2000-04-03       Impact factor: 3.641

2.  Microarray analysis identifies genes preferentially expressed in the lung schistosomulum of Schistosoma mansoni.

Authors:  Gary P Dillon; Theresa Feltwell; Jason P Skelton; Peter D Ashton; Patricia S Coulson; Michael A Quail; Nefeli Nikolaidou-Katsaridou; R Alan Wilson; Alasdair C Ivens
Journal:  Int J Parasitol       Date:  2005-11-15       Impact factor: 3.981

Review 3.  Granulomatous responses in larval taeniid infections.

Authors:  Á Díaz; C Sagasti; C Casaravilla
Journal:  Parasite Immunol       Date:  2018-04-10       Impact factor: 2.280

4.  Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection.

Authors:  H M Coutinho; L P Acosta; H W Wu; S T McGarvey; L Su; G C Langdon; M A Jiz; B Jarilla; R M Olveda; J F Friedman; J D Kurtis
Journal:  J Infect Dis       Date:  2006-12-13       Impact factor: 5.226

5.  Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.

Authors:  Rashika El Ridi; Hatem Tallima
Journal:  Vaccine       Date:  2008-12-03       Impact factor: 3.641

Review 6.  Protective immune mechanisms in helminth infection.

Authors:  Robert M Anthony; Laura I Rutitzky; Joseph F Urban; Miguel J Stadecker; William C Gause
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

7.  IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni).

Authors:  Christophe Chevillard; Carole Eboumbou Moukoko; Nasr-Eldin M A Elwali; Jay H Bream; Bourema Kouriba; Laurent Argiro; Siddig Rahoud; Adil Mergani; Sandrine Henri; Jean Gaudart; Qurashi Mohamed-Ali; Howard A Young; Alain J Dessein
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 8.  Human schistosomiasis.

Authors:  Daniel G Colley; Amaya L Bustinduy; W Evan Secor; Charles H King
Journal:  Lancet       Date:  2014-04-01       Impact factor: 79.321

Review 9.  Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections.

Authors:  Laura Adalid-Peralta; Gladis Fragoso; Agnes Fleury; Edda Sciutto
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

10.  Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.

Authors:  Fernanda C Cardoso; Gilson C Macedo; Elisandra Gava; Gregory T Kitten; Vitor L Mati; Alan L de Melo; Marcelo V Caliari; Giulliana T Almeida; Thiago M Venancio; Sergio Verjovski-Almeida; Sergio C Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2008-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.